RE: So Where Next And How27 Mar 2021 09:42
This is public forum and both side of the arguments need to be addressed, at the moment im on the negative side and its good to counter and have debate. Clearly i have a little softspot for gdr but i was very dissappointed with yesterdays meeting, they told us almost a month ago that the meeting will not have any new price sensitive info but yet some believed it would increase the sp while the opposite happened.
I was dissapointed with the way he answered questions and blamed solely on delays for not getting the licenses in countries. Budd needed to admit of their failures to sell any in uk and europe where they had licenses for nearly a year but he just blamed everything on fda delay and indian delays.
Its frustration regarding the fda, now many companies hold eua licenses for pcr and someone awhile ago put up article which stated more pcr test eua are getting refused by fda as there are many in the mkt in usa, so we need to take this into account.
Budd alluded if they cant get progress with our eua we may do one with beckman, again this will be time consuming and even budd admitted with other types of covid tests the pcr mkt will get smaller when someone asked regarding different covid tests.
We have some new investors who are clearly here for the bounce, the bounce will come and it will start to fall again.
Ppl go on about getting fda in Thailand, they have low rate of covid and they are vaccinating their population. We should be very concerned that rates are very high in europe but we struggling to sell any in europe.
We still have large background seller, for anyone to claim this to go back over £1 something big needs to happen. Multiple times the company has failed shareholders, when sp was over £1.60 and he did placing at 80p, where budd said sales are imminent and nothing happened.
All in all dyor, gdr has become riskier in my view.